Shenzhen Capital Group
Venture capitalShenzhen · Seed–Growth · 3 people tracked
Investment thesis
The page consists of an awards and recognition timeline rather than an explicit thesis statement. It indicates the firm invests across advanced manufacturing, healthcare and medical devices, semiconductors and integrated circuits, new materials, new energy and clean technology, enterprise services, AI and big data, next-generation information technology, and consumer sectors. The firm is repeatedly recognized as a leading state-owned and domestic Chinese venture capital institution, noted for fundraising, active investing, exits, post-investment management, fund-of-funds and secondary fund performance, and ESG. Its focus on 'specialized and sophisticated' (专精特新) companies and carbon-neutrality industries is emphasized across multiple years.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from public directoriesWhat they invest in
from 2 of 17 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×1
HQs:China×1
Investments · 17 tracked
founders shown can be your intro pathShenzhen Micropoint Bio is a life-science company that develops and mass-produces point-of-care diagnostic devices and microfluidic chips, with products covering cardiovascular, inflammation, reproductive, and coagulation testing.
BiotechHealthtechMedical DevicesShenzhen, CN
Co-investorsQiming Venture PartnersNorthern Light Venture CapitalSequoia Capital
Bioheng develops allogeneic CAR-T cell therapies for cancers and autoimmune diseases, using its Imviva platform and ANSWER technology with immune-evasion science to improve cell therapy performance and persistence.
BiotechHealthtech
Co-investorsDecheng CapitalGL VenturesHillhouse Capital
Industrial and collaborative robotics company.
Co-investorsTusStarXiang He Capital
Portfolio news
latest coverage across their companiesBioheng · rickscott.senate.gov · Mar 19, 2026
Frequently asked questions
- How many investments has Shenzhen Capital Group made?
- Shenzhen Capital Group has 15 tracked investments.
- What stage does Shenzhen Capital Group invest at?
- Shenzhen Capital Group invests at the Seed, Series A, Series B, Series C, Growth stages.
- What is Shenzhen Capital Group's typical check size?
- Shenzhen Capital Group typically writes checks of $1.5M – $156M.
- What sectors does Shenzhen Capital Group focus on?
- Shenzhen Capital Group focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Consumer, Energy, Enterprise Software, Healthtech, Medical Devices, New Materials, Robotics, Sector Agnostic, Semiconductors.
- Where is Shenzhen Capital Group located?
- Shenzhen Capital Group is headquartered in Shenzhen, CN.
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner, backing emerging and established fund managers who invest in technology-focused Canadian companies.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.